Femme et Homme
- | Pays :
- Israel
- | Organes : -
- | Spécialités : -
Extrait
The purpose of this study is to assess the clinical benefit and tolerability of adalimumab, a fully human monoclonal antibody to tumor necrosis factor α (TNF- α), in patients with ulcerative colitis (UC) naive to treatment with biologics.
Critère d'inclusion
- Ulcerative colitis